Archive for December 11th, 2011

ARIA presents positive ponatinib data at ASH + ARRY

Dec 11, 2011 No Comments by

 ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced preliminary clinical data showing that 47% of chronic-phase CML patients achieved a major response from the pivotal PACE trial, an ongoing Phase 2 study of ponatinib in patients with chronic myeloid leukemia (CML) or Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL), who are resistant or intolerant to dasatinib or nilotinib […]

Daily News Read more

Upcoming Catalysts as of December 9 2011

Dec 11, 2011 No Comments by

Some short and long term potential catalysts as of December 9 2011 (share prices as at the close of trading Friday, December 9, 2011). See the links in the FDA Calendar for more details about each catalyst. The possible catalysts listed below represent both short and long opportunities. It is NOT a recommendation to take […]

Catalysts Read more

Chart: VIVUS, Inc – VVUS

Dec 11, 2011 No Comments by

By @VexTrades – Upcoming Events December 2011 –  Top-line results due from its retrospective observational study of fetal outcomes in infants born to mothers exposed to topiramate during pregnancy or FORTRESS, in the offspring of women who were exposed to topiramate during the first trimester of pregnancy. Data will be used as part of the QNEXA NDA resubmission […]

Charts Read more